Delivery Order SPE2DB22D2006-SPE2DB25FW4FT
- Not listed
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Airsupra 90-80 mcg inhalers (10.7 gm) with a ceiling value of $3,435.48. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,762.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Airsupra 90-80 microgram inhaler (10.7 grams) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside competitive award is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of AIRSUPRA 90-80 MCG Inhaler 10.7GM with a ceiling value of $1,315.45. This delivery order is issued under a firm fixed price contract with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $14,808.52 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Airsupra 90-80 microgram inhaler units (10.7 grams). This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,376.37 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical product. This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,652.36 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a pharmaceutical product supporting federal medical supply needs. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Airsupra 90-80 microgram inhalers (10.7 grams) with a ceiling value of $3,441.57. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4FTDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,023.20 delivery order on September 16, 2025, for Airsupra 90-80 mcg inhaler 10.7gm pharmaceutical supplies to support federal medical procurement needs. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal contracting relationship with the Defense Logistics Agency. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen holds a critical role in the federal medical supply chain, serving military and veteran healthcare systems through a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill federal procurement requirements across multiple therapeutic domains on both small-value and substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/16/25 |